extracellular
matrix
metalloproteinas
induc
also
known
emmprin
basigin
plasma
membranebound
glycoprotein
function
adhes
molecul
express
high
level
varieti
malign
human
cancer
immort
cell
line
laboratori
previous
identifi
novel
hepatoma
associ
antigen
name
obtain
clone
human
hepatocellular
carcinoma
hcc
cdna
librari
screen
antihepatoma
monoclon
antibodi
nucleotid
acid
amino
acid
sequenc
ident
highli
express
hcc
cell
tissu
increas
express
stimul
growth
invas
hcc
cell
much
function
cancer
cell
acquisit
resist
anoiki
form
apoptosi
trigger
loss
alter
cellcel
cellmatrix
anchorag
critic
surviv
cell
tumor
progress
suspens
growth
use
engin
resist
anoiki
emerg
hallmark
metastat
cancer
cell
import
tumor
progress
increas
surviv
time
absenc
cell
anchorag
facilit
migrat
reattach
therefor
increas
probabl
metastasi
furthermor
acquisit
anoiki
resist
requir
cell
use
engin
adapt
suspens
cultur
spheroid
growth
recent
report
anoiki
suppressor
promot
anchorageindepend
growth
stimul
hyaluronan
product
regul
anoiki
signal
pathway
upregul
bim
howev
clear
whether
role
anoiki
resist
relat
cell
adhes
basic
function
molecul
addit
role
stimul
matrix
metalloproteinas
mmp
secret
differ
bioactiv
epitop
involv
regul
cell
adhes
identifi
also
report
particip
form
compact
cell
aggreg
regul
fibronectin
matrix
assembl
cellcel
adhes
bind
mab
may
mimic
natur
ligandreceptor
bind
induc
homotyp
monocyt
cell
aggreg
via
pathway
contrast
cho
report
antibodi
potent
inhibitor
homotyp
aggreg
induc
via
ligat
establishmentmainten
cellcel
contact
consid
import
environment
condit
physiolog
resist
anoiki
hypothes
may
confer
anoiki
resist
mediat
cellcel
adhes
unfortun
direct
evid
role
mediat
cellcel
contact
anoiki
resist
limit
even
selfcontradictori
furthermor
clear
whether
directli
involv
cell
adhes
either
adhes
signal
transmit
molecul
regul
aim
explor
whether
involv
form
cellcel
contact
whether
contribut
role
regul
anoiki
resist
transform
cell
line
human
embryon
kidney
hek
chosen
model
previou
result
confirm
cell
express
also
acquir
anoikisresist
subpopul
anoikissensit
parent
cell
togeth
two
cell
type
provid
ideal
model
explor
role
cellcel
adhes
molecul
prevent
anoiki
result
show
cellcel
contact
confer
anoiki
resist
function
also
involv
ecadherin
express
cell
spheroid
explor
role
cellcel
contact
prevent
anoiki
gener
subpopul
anoikisresist
phenotyp
deriv
cell
use
sequenti
cycl
adhes
suspens
cultur
upon
detach
apoptot
ratio
cell
lower
parent
cell
shown
quantifi
proport
flow
cytometri
versu
data
shown
cell
cultur
suspens
day
mean
proport
respect
littl
chang
apoptot
ratio
fig
moreov
subpopul
maintain
anoiki
resist
phenotyp
vitro
month
data
shown
addit
h
suspens
cultur
cell
spontan
gradual
form
cellcel
contact
gener
multicellular
spheroid
could
still
grow
adhes
cultur
wherea
parent
cell
fig
ultrastructur
examin
demonstr
suspend
spheroid
compris
mani
singl
cell
spheroid
chromatin
mass
moder
electron
densiti
dispers
nuclei
nucleoli
conspicu
fig
arrow
cell
within
multicellular
spheroid
adher
later
divers
special
intercellular
junction
fig
arrowhead
pretreat
edta
solut
disrupt
calciumdepend
cellcel
contact
also
disrupt
adhes
caus
massiv
dna
fragment
cell
shown
tunel
assay
fig
interestingli
singl
cell
detach
aggreg
gave
intens
tunel
stain
fig
arrowhead
contrast
tunel
assay
ultrastructur
examin
demonstr
cell
clearli
underw
anoiki
data
shown
previous
report
cellcel
contact
prevent
anoiki
primari
human
colon
epitheli
cell
present
result
also
suggest
adjac
epitheli
cell
form
cellcel
contact
suppress
anoiki
matrixdefici
condit
next
explor
whether
involv
cell
spheroid
surviv
mediat
cellcel
contact
express
compar
cell
suspens
cultur
cell
express
significantli
parent
cell
h
fig
posit
immunofluoresc
stain
restrict
cellcel
contact
fig
merg
arrowhead
result
may
impli
correl
cellcel
contactsdirect
anoiki
resist
level
express
similar
cell
type
adhes
cultur
data
shown
obtain
insight
correl
cell
treat
sirna
adhes
cultur
apoptosi
cellcel
contact
format
determin
suspens
cultur
express
reduc
fig
p
cell
underw
anoiki
proport
fig
cellcel
contact
format
total
inhibit
suspens
wherea
control
cell
form
multicellular
aggreg
littl
h
suspens
fig
result
indic
confer
anoiki
resist
cell
anoiki
mediat
cellcel
contact
format
upon
detach
anchorageindepend
ewe
sarcoma
cell
suppress
anoiki
pathway
involv
ecadherindepend
cellcel
adhes
thu
explor
whether
ecadherin
also
involv
suppress
anoiki
mediat
cellcel
adhes
cell
anticip
increas
ecadherin
express
confirm
cell
h
suspens
cultur
fig
b
p
posit
stain
partli
locat
around
cellcel
contact
fig
also
signific
express
ecadherin
complet
suspend
parent
cell
initi
suspend
cell
found
immunofluoresc
reason
explan
could
ecadherin
express
decreas
dramat
upon
cellcel
detach
addit
reduct
ecadherin
express
sirna
fig
e
p
determin
western
blot
total
inhibit
cellcel
contact
format
fig
decreas
degre
cell
aggreg
score
describ
method
knockdown
ecadherin
led
mark
increas
mean
proport
littl
shift
peak
flow
cytometr
histogram
fig
p
also
decreas
cellular
dna
content
via
fluoresc
dye
bind
determin
nf
cell
prolifer
assay
kit
fig
p
close
proport
cell
number
result
suggest
cellcel
contact
format
anoiki
resist
cell
may
also
mediat
ecadherin
ecadherin
relat
cellcel
contactdirect
surviv
cell
suspens
may
function
connect
test
hypothesi
investig
relationship
two
molecul
rnai
fig
b
show
ecadherin
express
decreas
dramat
sirnatr
cell
accord
immunofluoresc
stain
densiti
fig
analyz
imag
pro
plu
softwar
p
data
shown
western
blot
p
interestingli
time
sirna
treatment
cellcel
contact
spheroid
gradual
disrupt
fig
contrast
block
ecadherin
bind
antiecadherin
inhibit
cellcel
contact
edta
show
signific
effect
express
singl
cell
level
accord
immunofluoresc
stain
fig
fluoresc
densiti
analyz
imag
pro
plu
p
data
shown
although
degre
cell
aggreg
decreas
suspens
cultur
fig
p
furthermor
treatment
cell
ecadherin
sirna
adhes
condit
alter
level
express
suspens
fig
p
fig
p
togeth
result
indic
effect
cellcel
adhes
anoiki
suppress
mediat
ecadherin
pathway
involv
ecadherin
cell
adhes
surviv
determin
situat
investig
whether
two
pathway
involv
cellcel
contactdirect
surviv
suspens
spheroid
treat
specif
competit
inhibitor
erk
inhibitor
shown
fig
b
inhibit
cellcel
contact
format
decreas
degre
cell
aggreg
dosedepend
manner
tunel
assay
show
treatment
result
posit
stain
tunel
cell
fig
arrowhead
addit
decreas
rel
fluoresc
intens
indic
cellular
dna
content
dosedepend
manner
newmankeul
multipl
comparison
test
p
versu
fig
result
indic
treatment
decreas
cell
number
suspens
dosedepend
manner
cellular
dna
content
via
fluoresc
dye
bind
close
proport
cell
number
base
instruct
assay
kit
describ
method
contrast
significantli
affect
rel
fluoresc
intens
even
fig
result
indic
pathway
inhibit
suppress
cellcel
contact
format
result
decreas
cell
number
suspend
cell
anoiki
resist
key
surviv
cell
malign
transform
metastasi
may
also
key
adapt
cell
suspens
cultur
spheroid
growth
use
engin
epitheli
cell
suppress
anoiki
upon
detach
seem
induc
cellcel
contact
form
exampl
cadherinmedi
homotyp
interact
maintain
surviv
human
prostat
carcinoma
cell
absenc
extracellular
matrix
ecm
attach
also
disrupt
ecadherin
cellcel
contact
show
import
suppress
anoiki
normal
enterocyt
detach
villu
epithelium
compar
cellecm
disrupt
growth
spheroid
render
tumor
cell
less
sensit
exogen
apoptot
stimuli
spheroid
greater
drug
resist
correspond
monolay
cell
use
engin
also
grow
spheroid
suspens
thu
elucid
mechan
spheroid
surviv
cellcel
contact
potenti
profound
valu
understand
surviv
mechan
cell
may
also
appli
control
growth
cell
use
biomed
engin
howev
much
less
known
surviv
pathway
activ
anchorageindepend
matrixdefici
condit
cell
recent
marieb
et
al
found
adhes
molecul
promot
anchorageindepend
hyaluronandepend
growth
human
breast
carcinoma
cell
also
report
regul
cellmatrix
adhes
howev
clear
whether
cellcel
contact
role
anoiki
resist
growth
spheroid
cell
use
engin
use
sophist
model
establish
anoikisresist
parent
cell
found
cellcel
adhes
suppress
anoiki
ecadherindepend
manner
addit
shown
cellcel
adhesionbas
surviv
signal
aris
adjac
cell
may
inhibit
anoiki
manner
fig
b
c
result
indic
cellcel
contact
mediat
anoiki
resist
specif
ecadherindepend
pathway
anoiki
suppress
mediat
cellcel
contact
cell
involv
pathway
although
data
suggest
elev
express
correl
progress
invas
potenti
human
hepatoma
cell
role
cellcel
contact
acquir
resist
anoiki
remain
obscur
earlier
evid
suggest
promot
cancer
cell
surviv
regul
intercellular
contact
inhibit
anoiki
studi
cell
transfect
gene
express
differ
level
use
studi
first
found
evid
elev
endogen
express
contribut
cellcel
adhes
subsequ
confer
resist
anoiki
suspens
condit
fig
b
c
e
f
anoikisresist
cell
model
would
suitabl
investig
cellcel
contactdirect
anoiki
suppress
sinc
closer
natur
vivo
statu
physiolog
model
cell
use
engin
addit
owe
use
cell
biotechniqu
cell
model
elucid
cell
spheroid
mechan
may
relev
bioengin
cellcel
contacttrigg
cell
surviv
also
involv
antiapoptot
signal
ecadherin
src
pathway
instanc
e
cadherin
classic
cadherin
promot
calciumdepend
cellcel
adhes
suppress
anoiki
squamou
carcinoma
normal
proxim
tubular
cell
ewe
tumor
spheroid
ecadherin
cellcel
contact
may
activ
rtk
signal
pathway
homophil
ecadherin
bind
also
involv
activ
akt
kinas
ultim
inhibit
activ
prevent
anoiki
found
ecadherin
express
elev
anoikisresist
cell
fig
b
c
h
suspens
cultur
also
high
level
ecadherin
express
inhibit
anoiki
mediat
cellcel
contact
upon
cellmatrix
detach
requir
function
anoiki
suppressor
likewis
knockdown
disrupt
cellcel
contact
anoiki
ensu
fig
e
f
addit
comparison
ecadherin
express
parent
cell
focus
contrast
protein
h
suspens
cultur
time
cours
long
enough
stabilis
ligat
ecadherin
may
preclud
ecadherin
increas
stabilis
ligat
ecadherin
site
adhes
therefor
help
valu
function
protein
accur
anoiki
resist
import
conclus
may
promin
role
suppress
anoiki
ecadherin
ecadherin
may
downstream
effector
develop
anoiki
resist
although
precis
mechan
ecadherin
complex
remodel
degrad
remain
determin
pronounc
effect
knockdown
cell
surviv
may
result
direct
decreas
ecadherin
express
subsequ
loss
cellcel
contact
fig
b
c
addit
recent
data
shown
specif
inhibitor
significantli
reduc
effect
cell
adhes
metastat
invas
p
human
hepatoma
cell
ecadherin
predominantli
express
cellcel
contact
stabli
bound
complex
protein
express
necessari
suffici
activ
pathway
also
demonstr
cellcel
contact
mediat
cell
surviv
anchorageindepend
condit
ecadherindepend
manner
cellcel
contact
mediat
resist
anoiki
involv
pathway
model
base
result
may
least
part
infer
confer
anoiki
resist
ecadherin
mediat
cellcel
contact
may
activ
pathway
promot
spheroid
format
establish
cellcel
contact
howev
wish
impli
ecadherin
stimul
surviv
via
stimul
sinc
occur
directli
respons
ecadherin
upregul
model
affect
ecadherin
express
need
investig
use
sophist
anoikisresist
model
develop
reveal
novel
role
cellcel
adhes
lead
anoiki
resist
cell
spheroid
growth
result
support
observ
confer
anoiki
resist
ecadherinmedi
cellcel
contact
cellcel
mediat
resist
anoiki
shown
involv
pathway
cell
contactdirect
surviv
import
tumor
cell
metastasi
invas
result
relev
bitter
understand
cell
surviv
mechan
seen
tumor
progress
furthermor
except
cell
lymphoid
origin
cultur
mammalian
cell
use
bioengin
need
adapt
suspens
condit
growth
also
capabl
form
spheroid
suspens
surviv
result
also
relev
understand
surviv
mechan
cell
cell
line
obtain
cell
bank
type
cultur
collect
chines
academi
scienc
shanghai
china
cell
acquir
laboratori
stock
china
center
type
cultur
collect
number
cctcc
cell
cultur
rpmi
supplement
heatinactiv
fetal
bovin
serum
fb
humidifi
atmospher
contain
methocel
medium
consist
rpmi
supplement
methocel
fb
cell
detach
cultur
modif
suspens
cultur
procedur
previous
describ
briefli
flask
coat
steril
agar
supplement
rpmi
fb
everi
day
cultur
flask
refe
regularli
care
remov
old
medium
ad
ml
fresh
methocel
medium
cultur
monitor
routin
ensur
free
mycoplasma
fungal
bacteri
contamin
cell
line
discard
two
month
new
line
propag
frozen
stock
small
interf
rna
sirna
target
ecadherin
genbank
access
gener
sirnaecad
siecadherincad
synthes
ambion
inc
cell
transfect
sirna
use
lipofectin
invitrogen
ltd
usa
accord
manufactur
instruct
briefli
cell
exponenti
growth
phase
transfect
correspond
target
sirna
nmoll
scrambl
rna
mocktreat
lipofectin
serum
antibioticfre
rpmi
medium
control
transient
transfect
cell
grown
h
replat
agarco
sixwel
plate
cell
incub
h
experi
conduct
silenc
neg
control
sirna
ambion
usa
use
similar
condit
neg
control
morpholog
apoptot
cell
assess
phasecontrast
olympu
japan
electron
microscopi
em
briefli
cell
cultur
cell
detach
condit
indic
time
observ
photograph
evalu
subcellular
morpholog
characterist
apoptosi
transmiss
electron
microscopi
tem
jeol
japan
scan
electron
microscopi
sem
n
hitachi
japan
use
previouslydescrib
method
sampl
view
independ
section
least
cellssect
detect
fragment
dna
apoptot
cell
deadendem
colorimetr
tunel
system
promega
usa
use
accord
manufactur
protocol
cell
detach
attach
cultur
score
incid
tunel
stain
use
phasecontrast
microscopi
apoptot
nuclei
tunel
condens
chromatin
darkli
stain
dna
fragment
also
quantifi
flow
cytometri
becton
dickinson
usa
use
dna
reagent
kit
bechman
coulter
inc
usa
fluoresc
intens
propidium
iodid
pi
measur
nm
histogram
yaxi
number
cell
count
label
count
xaxi
dna
size
content
cell
regist
label
cell
normal
dna
intens
fluoresc
apoptot
cell
fragment
dna
lower
fluoresc
intens
region
left
side
normal
peak
apoptot
number
cell
region
divid
total
cell
count
indic
percentag
apoptosi
sampl
minimum
cell
examin
least
three
time
gate
sidescatt
plot
exclud
debri
gate
puls
width
plot
exclud
remain
cell
aggreg
analysi
format
cellcel
contact
disturb
use
calcium
chelat
ecadherin
antibodi
briefli
cell
seed
agarco
sixwel
plate
treat
mmoll
edta
h
altern
cell
treat
mous
antiecadherin
abcam
ltd
cambridg
uk
amount
goat
igg
sigma
usa
use
control
degre
cell
aggreg
score
follow
aggreg
cellsaggreg
cellsaggreg
cellsaggreg
greater
cellsaggreg
photograph
taken
olympu
camera
invert
microscop
cell
harvest
lysi
buffer
total
protein
quantifi
use
bca
equal
amount
protein
subject
sodium
dodecyl
sulfat
polyacrylamid
gel
electrophoresi
sdspage
nonreduc
condit
separ
protein
transfer
polyvinyliden
difluorid
pvdf
membran
millipor
bedford
immunoblot
appropri
primari
antibodi
follow
primari
antibodi
use
human
hepatoma
monoclon
prepar
laboratori
antiecadherin
mous
monoclon
abcam
ltd
cambridg
uk
hrpconjug
rabbitantimous
immunoglobulin
pierc
rockford
il
use
secondari
antibodi
abcam
ltd
cambridg
uk
use
load
control
two
major
form
kda
analyz
previous
describ
immunoreact
band
visual
use
chemiluminesc
substrat
detect
system
ge
healthcar
usa
ecadherin
western
blot
done
previous
describ
quantif
band
two
similar
experi
done
use
gene
tool
imag
softwar
n
cell
harvest
dri
coverslip
fix
iceaceton
min
fix
cell
block
nonfat
milk
h
incub
mab
antiecadherin
mous
monoclon
antibodi
abcam
ltd
cambridg
uk
block
solut
h
stain
fitcconjug
antimous
igg
pierc
rockford
h
final
nuclei
stain
ngml
dapi
biotium
hayward
usa
pb
min
stain
cell
examin
laser
scan
confoc
microscop
olympu
tokyo
japan
fluoresc
densiti
confoc
imag
measur
imag
pro
plu
cell
treat
erk
inhibitor
sigma
usa
inhibitor
sigma
usa
dmso
vehicl
control
h
adhes
condit
treat
cell
cultur
celldetach
condit
indic
time
cellcel
contact
observ
invert
phasecontrast
microscop
cell
number
evalu
nf
cell
prolifer
assay
kit
invitrogen
ltd
usa
base
measur
cellular
dna
content
via
fluoresc
dye
bind
fluoresc
intens
sampl
measur
use
fluoresc
micropl
reader
excit
nm
emiss
detect
nm
experiment
protocol
assay
done
accord
manufactur
instruct
nonadher
cell
data
express
mean
sd
least
three
independ
experi
statist
analysi
perform
student
ttest
newmankeul
multipl
comparison
test
use
spss
statist
softwar
statist
test
twosid
p
valu
consid
statist
signific
xkm
lw
carri
experiment
protocol
particip
design
experi
perform
experi
draft
manuscript
yl
pz
ht
xmi
collect
microscop
imag
anoikisresist
cell
help
draft
manuscript
pz
znc
conceiv
studi
particip
design
coordin
also
involv
draft
manuscript
author
read
approv
final
manuscript
